July 15, 2026

Press Release: ECOG-ACRIN ENDURANCE trial findings published in the New England Journal of Medicine provide the first randomized evidence on the optimal duration of lenalidomide maintenance for patients with newly diagnosed multiple myeloma

July 9, 2026

Podcast: ASCO Post includes updated STAMP (EA6174) Merkel cell carcinoma data in its ASCO26 highlights, applauding cooperative groups for their ability to study rare cancers

June 29, 2026

The June 2026 News from ECOG-ACRIN blog is now available

May 28, 2026

The May 2026 News from ECOG-ACRIN blog is now available

April 27, 2026

The April 2026 News from ECOG-ACRIN blog is now available

March 30, 2026

The March 2026 News from ECOG-ACRIN blog is now available

February 27, 2026

The February 2026 News from ECOG-ACRIN blog is now available

February 3, 2026

ECOG-ACRIN legacy lung cancer studies E1594 and E5508 cited in ASCO Living Guideline 2026.3.0, therapy for stage 4 NSCLC without driver alterations

January 31, 2026

The January 2026 News from ECOG-ACRIN blog is now available

ECOG-ACRIN Cancer Research Group